OQS
HGEN

Occudo Quantitative Strategies’s HUMANIGEN, INC. HGEN Stock Holding History

Occudo Quantitative Strategies’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-113,359
Closed -$201K – 1489
2022
Q2 		$201K Sell
113,359
-4,656
-4% -$10.5K 0.02% 912
2022
Q1 		$355K Sell
118,015
-4,883
-4% -$13.1K 0.03% 762
2021
Q4 		$457K Buy
122,898
+105,979
+626% +$620K 0.04% 645
2021
Q3 		$100K Buy
+16,919
New +$238K 0.01% 923

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Occudo Quantitative Strategies's HGEN Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 113,359 shares — an estimated $201K sold.

Occudo Quantitative Strategies first reported a position in HGEN in Q3 2021 and held it in 4 quarters. The position peaked at $457K in Q4 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Occudo Quantitative Strategies reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 113,359 HUMANIGEN, INC. shares in Q3 2022, an estimated $201K.
  • Occudo Quantitative Strategies first reported a position in HUMANIGEN, INC. in Q3 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's HUMANIGEN, INC. position peaked at $457K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.